Shearman & Sterling represented Quest Diagnostics Incorporated in a shelf takedown of $500 million aggregate principal amount of its 4.200% senior notes due 2029. Goldman Sachs, Mizuho Securities, Morgan Stanley, J.P. Morgan Securities and Wells Fargo Securities acted as joint book-running managers for the offering.

Quest Diagnostics Incorporated is the world’s leading provider of diagnostic information services.

The Team